The Pharmacy Times® Asthma resource center provides clinical news and articles, coverage from conferences and meetings, links to condition-specific resources, and videos and other content.
What can we help you find?
Smart inhalers have the potential to address the challenges faced by patients and health care professionals in the management of respiratory diseases.
Those wearing a facemask while exercising may feel an increased sensation of dyspnea, however, there is little evidence that this medical condition is occurring.
Study: Benralizumab Eliminated Oral Corticosteroid Use in Majority of Oral Corticosteroid-Dependent Asthma Patients
Frequent or chronic use of oral corticosteroids can lead to serious adverse effects in patients with asthma, including weight gain, diabetes, immunosuppression, and adrenal insufficiency.
Digital health tools were a major theme during the first-ever NASP Challenge, comprising 4 of the 5 finalists.
The triple combination therapy is the first single inhaler triple therapy approved for both asthma and COPD and is the only single inhaler triple therapy available as a once-daily inhalation.
Contrary to earlier statements from the CDC, study suggests corticosteroid inhalers used by many asthmatics might make it more difficult for COVID-19 to enter the airways.
New research contradicts previous observational studies on the effect of vitamin D supplements in severe asthma prevention.
Week in Review: Researchers Investigate Whether Asthma Increases Risk of Contracting, Severity of COVID-19
Top news of the week from Pharmacy Times®.
As a chronic respiratory disease, asthma has been considered a risk factor for COVID-19 by many experts and clinicians.
The inhaler sends data back to a mobile app in real time.
Contrary to World Health Organization recommendations, the benefits of steroids used in inhalers and nebulizers outweigh the risks.
The dupilumab pen features a hidden needle and single-press auto-injection, along with visual and audio feedback to help with administration.